Edible and Medicinal Mushrooms: Emerging Brain Food for the Mitigation of Neurodegenerative Diseases.

  title={Edible and Medicinal Mushrooms: Emerging Brain Food for the Mitigation of Neurodegenerative Diseases.},
  author={Chia-Wei Phan and Pamela David and Vikineswary Sabaratnam},
  journal={Journal of medicinal food},
  volume={20 1},
There is an exponential increase in dementia in old age at a global level because of increasing life expectancy. The prevalence of neurodegenerative diseases such as dementia and Alzheimer's disease (AD) will continue to rise steadily, and is expected to reach 42 million cases worldwide in 2020. Despite the advancement of medication, the management of these diseases remains largely ineffective. Therefore, it is vital to explore novel nature-based nutraceuticals to mitigate AD and other age… 

Figures and Tables from this paper

A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders.
The role of the medicinal properties of different medicinal mushrooms that contain bioactive compounds with a protective effect against neuronal dysfunction will facilitate the development of drugs against neurodegenerative diseases.
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease
The present contribution will attend to the most popular and effective nutraceuticals with proposed brief mechanisms entailing antioxidant, anti-inflammatory, autophagy regulation, mitochondrial homeostasis, and more.
Edible Mushrooms as Neuro-nutraceuticals: Basis of Therapeutics
Mushrooms, the macro-fungi with distinctive fruiting bodies and mycelia, are valued throughout the world not only for their nutritive values but also for their medicinal uses. The former desirable
A review of the therapeutic and biological effects of edible and wild mushrooms
This review aims to provide a clear insight on the commercially cultivated, wild edible, and medicinal mushrooms with comprehensive information on their phytochemical constituents and properties as part of food and medicine for futuristic exploitation.
Biomolecules of mushroom: a recipe of human wellness
The current status of the medicinal attributes of mushrooms and their biomolecules in different diseases such as cardiovascular, diabetes, reproductive diseases, cancer, and neurodegenerative diseases are reviewed.
Recent Progress in Research on the Pharmacological Potential of Mushrooms and Prospects for Their Clinical Application
This review discusses recent advances in research on the pharmacological potential of mushrooms and perspectives for their clinical application.
Making Use of Genomic Information to Explore the Biotechnological Potential of Medicinal Mushrooms
Examples of recent identification of genes and gene clusters for bioactive compounds in medicinal and edible fungi, including different terpenoids, phenolics, polyketides, cyclic peptides, aegerolysins, lectins, protease inhibitors, and ribosome-inactivating proteins are presented.
Neuroprotective Effects of Extracts from Tiger Milk Mushroom Lignosus rhinocerus Against Glutamate-Induced Toxicity in HT22 Hippocampal Neuronal Cells and Neurodegenerative Diseases in Caenorhabditis elegans
It is found that only LRE exhibited neuroprotective effects both in vitro (alleviation of glutamate-induced ROS in HT22 cells, resulting in increased cell survival) and in vivo (prevention of neurotoxicity in C. elegans).


Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism
Over 20 different brain-improving culinary-medicinal mushrooms and at least 80 different bioactive secondary metabolites isolated from them reduced beta amyloid-induced neurotoxicity and had anti-acetylcholinesterase, neurite outgrowth stimulation, nerve growth factor synthesis, neuroprotective, antioxidant, and anti-(neuro)inflammatory effects are reviewed.
Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?
A multi‐faceted review of medicinal plants or phytochemicals, including traditional uses, relevant bioactivities, psychological and clinical evidence on efficacy and safety, focuses on those for which there is promising clinical trial evidence in people with dementia, together with at least one other of these lines of supporting evidence.
Hericium erinaceus: an edible mushroom with medicinal values
The recent advances in the research and study on H. erinaceus are overviewed and the potential health beneficial activities of this mushroom are discussed, with the recognition of bioactive compounds responsible for these medicinal properties.
Antitumor activity of mushroom polysaccharides: a review.
This review aims to integrate the information regarding nutritional, chemical and biological aspects of polysaccharides in mushrooms, which will possibly be employed to elucidate the correlation between their structural features and biological functions.
Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides
  • S. Wasser
  • Biology, Medicine
    Applied Microbiology and Biotechnology
  • 2002
The present review analyzes the pecularities of polysaccharides derived from fruiting bodies and cultured mycelium in selected examples of medicinal mushrooms and concludes that high molecular weight glucans appear to be more effective than those of low molecular weight.
Curcumin: the Indian solid gold.
Curcumin has been shown to exhibit antioxidant, anti-inflammatory, antiviral, antibacterial, antifungal, and anticancer activities and thus has a potential against various malignant diseases, diabetes, allergies, arthritis, Alzheimer's disease, and other chronic illnesses.
Recent developments in mushrooms as anti-cancer therapeutics: a review
The present review updates the recent findings on the pharmacologically active compounds, their anti-tumor potential, and underlying mechanism of biological action in order to raise awareness for further investigations to develop cancer therapeutics from mushrooms.
Food‐derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice
ERGO is a typical substrate of carnitine/organic cation transporter OCTN1/SLC22A4, which is expressed in the brain and neuronal stem cells, although little is known about its permeation through the BBB (blood–brain barrier) or its neurological activity.